"Gliosarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Rare mixed tumors of the brain and rarely the spinal cord which contain malignant neuroectodermal (glial) and mesenchymal components, including spindle-shaped fibrosarcoma cells. These tumors are highly aggressive and present primarily in adults as rapidly expanding mass lesions. They may arise in tissue that has been previously irradiated. (From Br J Neurosurg 1995 Apr;9(2):171-8)
| Descriptor ID |
D018316
|
| MeSH Number(s) |
C04.557.465.625.600.380.400 C04.557.470.670.380.400 C04.557.580.625.600.380.400
|
| Concept/Terms |
Gliosarcoma- Gliosarcoma
- Gliosarcomas
- Glioblastoma with Sarcomatous Component
- Sarcomatous Glioma
- Glioma, Sarcomatous
- Gliomas, Sarcomatous
- Sarcomatous Gliomas
|
Below are MeSH descriptors whose meaning is more general than "Gliosarcoma".
Below are MeSH descriptors whose meaning is more specific than "Gliosarcoma".
This graph shows the total number of publications written about "Gliosarcoma" by people in this website by year, and whether "Gliosarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Gliosarcoma" by people in Profiles.
-
Clinical and survival characteristics of primary and secondary gliosarcoma patients. Clin Neurol Neurosurg. 2022 03; 214:107146.
-
Gliosarcoma vs. glioblastoma: a retrospective case series using molecular profiling. BMC Neurol. 2021 Jun 23; 21(1):231.
-
Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma. J Neurooncol. 2018 Apr; 137(2):303-311.
-
Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. J Neurooncol. 2015 Nov; 125(2):401-10.
-
Therapeutic management of gliosarcoma in the temozolomide era. CNS Oncol. 2015; 4(3):171-8.
-
Annexin A5-functionalized nanoparticle for multimodal imaging of cell death. Mol Imaging. 2013 May; 12(3):182-90.
-
Temozolomide use in adult patients with gliosarcoma: an evolving clinical practice. J Neurooncol. 2013 Mar; 112(1):83-9.
-
Brain tumour targeting strategies via coated ferrociphenol lipid nanocapsules. Eur J Pharm Biopharm. 2012 Aug; 81(3):690-3.
-
Gliosarcoma stem cells undergo glial and mesenchymal differentiation in vivo. Stem Cells. 2010 Feb; 28(2):181-90.
-
A modified frontal-nasal-orbital approach to midline lesions of the anterior cranial fossa and skull base: technical note with case illustrations. Neurosurg Rev. 2010 Jan; 33(1):63-70.